Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
471.44
+3.85 (+0.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
2 Biotech Stocks to Buy Hand Over Fist in August
August 12, 2024
Both of these biotechs are highly innovative companies.
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
August 09, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in August 2024
August 08, 2024
These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.
Via
InvestorPlace
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
August 07, 2024
From
Vertex Pharmaceuticals
Via
Business Wire
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Shares of the rare disease drugmaker are already up more than 40% over the past year.
Via
The Motley Fool
Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook
August 01, 2024
The company's sales came in a hair light with losses wider than expected.
Via
Investor's Business Daily
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
July 31, 2024
Via
Benzinga
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Great companies are found in every type of market landscape.
Via
The Motley Fool
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!
Via
InvestorPlace
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
The biotech recently became a commercial-stage company.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
August 03, 2024
These two healthcare companies have far more upside potential than Johnson & Johnson.
Via
The Motley Fool
Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock.
July 25, 2024
Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing?
Via
Chartmill
3 Biotech Stocks That Could Have Investors Grinning Soon
August 02, 2024
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.
Via
InvestorPlace
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
August 02, 2024
Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New York, as a cooler-than-expected July jobs report rattled risk sentiment and...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
August 02, 2024
Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing the $4.14 consensus. The analyst expects strong growth in the pain...
Via
Benzinga
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
August 02, 2024
Vertex's first loss in years is a big nothingburger.
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
August 01, 2024
VRTX earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Vertex Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...
Via
Benzinga
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
August 01, 2024
These businesses are looking like increasingly attractive buys.
Via
The Motley Fool
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
August 01, 2024
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a...
Via
Benzinga
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.
Via
InvestorPlace
Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain
July 30, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.
Via
The Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
July 29, 2024
The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision.
Via
InvestorPlace
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
July 28, 2024
These companies are paving the way to future growth and market share in their respective industries.
Via
The Motley Fool
Is Vertex Pharmaceuticals' Monopoly in Danger?
July 25, 2024
As a shareholder, I am nowhere close to panic mode.
Via
The Motley Fool
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
July 25, 2024
Vertex shares have soared by triple-digit percentages over the past three years.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.